Skip to content

Bone Evaluation of Dental Implants Produced by 3D Printing in Mandible or Maxilla: clinical study

Marginal Bone Level Assessment of Additive-Manufactured Titanium Implants at 30 and 90 Days: 1-year non-inferiority within-subject randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9sjh5rm
Enrollment
Unknown
Registered
2022-11-25
Start date
2022-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loss of teeth due to accident, extraction or localized periodontal diseases

Interventions

For this two-arm non-inferiority within-subject randomized clinical trial, 75 patients in need of rehabilitation with dental implants in areas of the mandible or posterior maxilla (premolars and/or mo
D25.339.312

Sponsors

Universidade de São Paulo - Faculdade de Odontologia
Lead Sponsor
M3 Health Indústria e Comércio de Produtos Médicos, Odontológicos e Correlatos Sociedade Anônima
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who are a minimum age of 18 years and a maximum of 70 years; with good general health; who have signed the Informed Consent Form; in need of rehabilitation with dental implants in areas of mandible or posterior maxilla (premolars and/or molars); with bacterial plaque index = 20%; bleeding rate = 20%; sufficient alveolar bone volume for an implant of 8 or 10mm length, diameter of 3.5mm, 4.00mm or 4.5mm, with bone quality type I-III and no associated bone regeneration required

Exclusion criteria

Exclusion criteria: Pregnant and lactating women; uncontrolled diabetes; history of chemotherapy or radiotherapy in the last 5 years; radiation therapy to areas of the head and neck; use of immunosuppressants, bisphosphonates or prolonged use of corticosteroids; smokers; alcohol or drug abuse; untreated periodontitis; history of previous bone augmentate in the implant installation region; presence of residual roots at the site to receive the implant; type IV bone density; individuals with connective tissue disorders or bone metabolic diseases; postmenopausal osteoporosis or other systemic diseases that may affect bone metabolism; need for guided bone regeneration at the time of implant placement

Design outcomes

Primary

MeasureTime frame
The objective of this study will be to evaluate the non-inferiority of implants produced by additive manufacturing loaded in 30 days when compared with those loaded in 90 days, in relation to marginal bone loss, after 01 (one) year of follow-up.

Secondary

MeasureTime frame
Evaluate implant success rate, plaque index, peri-implant bleeding index, clinical probing depth, clinical level of insertion over 1 year after placement.

Countries

Brazil

Contacts

Public ContactThais Rojas

M3 Health Indústria e Comércio de Produtos Médicos, Odontológicos e Correlatos Sociedade Anônima

thais.rojas@plenum.bio+55(11)31099044

Outcome results

None listed

Source: REBEC (via WHO ICTRP)